medRxiv · Jun 15, 2026
Nocturnal Respiratory Rate and Variability Predict Long-term Mortality in Stable Outpatients with Cardiovascular Disease
By Padrós-Valls R, Gupta K, Harrington N et al.
BACKGROUND: Respiratory rate (RR) predicts short-term mortality in acute care settings, yet its prognostic significance in clinically stable outpatients remains poorly defined. OBJECTIVES: To determine whether the median and variability of nocturnal respiratory rate (NRR) are independently associated with long-term cardiovascular and all-cause mortality in outpatients with cardiovascular disease. METHODS: We analyzed overnight chest belt waveforms from elective polysomnography in 5,679 older adults with cardiovascular disease enrolled in the Sleep Heart Health Study (SHHS). NRR was quantified at 30-second resolution, and per-subject median NRR and within-night variability (standard deviation) were derived. Kaplan-Meier survival analysis and Cox proportional hazards models were used to evaluate associations with cardiovascular and all-cause mortality over 3-year and 15-year follow-up periods, adjusting for demographic characteristics, cardiopulmonary comorbidities, and sleep apnea severity. RESULTS: Higher median NRR and greater NRR variability were each associated with increased cardiovascular and all-cause mortality. Combining these metrics identified a high-risk group characterized by high median and high variability of NRR, with nearly five-fold higher 3-year all-cause mortality compared with a low-risk group (unadjusted HR: 2.61; 95% CI: 1.65, 4.14; p <0.001; adjusted HR: 2.15; 95% CI: 1.30, 3.55; p =0.003). CONCLUSIONS: Both the baseline level and variability of NRR independently predict morttality in clinically stable outpatients with cardiovascular disease. Densely profiled NRR represents a promising, underutilized biomarker for long-term risk stratification. CONDENSED ABSTRACT: Nocturnal respiratory rate (NRR) is an underutilized biomarker whose prognostic significance in stable cardiovascular outpatients is unknown. In 5,679 participants from the Sleep Heart Health Study, median NRR and within-night variability derived from overnight polysomnography independently predicted cardiovascular and all-cause mortality. Stratification based on these metrics identified a high-risk group with nearly five-fold higher 3-year mortality compared with a low-risk group (adjusted HR: 2.15; 95% CI: 1.30-3.55; p =0.003).
doi.org/10.64898/2026.06.12.26355214Open accessPubMed 42369522Biomarkers